Swedish Orphan Biovitrum is acquiring CTI Biopharma in a $1.7 billion deal centered on the biotech’s commercialized drug for the blood cancer myelofibrosis. Sobi says the drug, Vonjo, complements one of its own assets approved for a different blood disorder.
Sobi said it plans to seek FDA approval of the gout drug, SEL-212, in 2024. If approved, it would compete against Krystexxa, a Horizon Therapeutics drug projected to become a blockbuster seller.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Nobel Prize in Medicine or Physiology went to Drs. William Kaelin, Gregg Semenza and Peter Ratcliffe. Their research has led to new strategies for treating diseases like cancers and anemia.
On Friday, Novartis presented data at ECTRIMS showing that Arzerra had superior efficacy to Sanofi's Aubagio. Johnson & Johnson's Janssen division had presented data for its drug, ponesimod, two days before.
In a phone interview, CEO Jakob Lindberg indicated that data so far showed a study was doing well in terms of progression-free survival.
The Swedish drugmaker acquired rights to the drug from Switzerland-based Novimmune in July for about $50 million, plus about $400 million in payments over eight years.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Sobi buys US rights to Synagis, currently the only drug approved for treating RSV, along with 50 percent of US earnings for its successor, the Phase II MEDI8897.
The challenge with radiation and other cancer therapies is getting the right amount of treatment to the tumor and leaving healthy cells unscathed.
Pond Healthcare Innovation CEO Daniel Taub said in an interview that the Air Smart spirometer device is CE-certified by European regulators and is available in Europe
Swedish startup Jojnts has developed a digital version of a national program to help people diagnosed with osteoarthritis better manage their condition. The idea is that by providing an app for the program the company will be able to find a global audience in search of a way to treat osteoarthritis in a way that […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Eyeglasses have undergone more technology advancements in the past 10 years than any other decade since they were invented in 1252. PixelOptics developed glasses that can be electronically adjusted by users. There’s Google Glass, which is giving rise to all sorts of different smart glass applications in healthcare. There are even glasses that can help […]
Dermelle, LLC (aka EternoGen, LLC), a Columbia, Missouri-based startup that works with collagen scaffolds for soft tissue therapeutic applications, has raised $920,427 to close its series A funding. This money will pay for the “full spectrum of safety tests” and pilot human studies to position the company for a regulatory clinical study in Europe and […]